Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fludarabine
Breast Carcinoma
Essen BiotechP2B (60)
Fludarabine
Primary Central Nervous System Lymphoma
City of Hope Medical CenterP2B (60)
Fludarabine
Cutaneous Neuroendocrine Carcinoma
Sotio Biotech Inc.P2B (60)
Fludarabine
Mesothelioma
National Cancer Institute (NCI)P2B (60)
Fludarabine
Osteosarcoma
M.D. Anderson Cancer CenterP2B (60)
Fludarabine
Soft Tissue Sarcoma
Medigene AGP2B (60)
Fludarabine
T-Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (60)
Fludarabine
Uveal Melanoma
Beijing BiotechP2B (60)
Fludeoxyglucose
Anal Carcinoma
Jonsson Comprehensive Cancer CenterP2B (60)
Fludeoxyglucose
HER2 Positive Breast Carcinoma
University of Alabama at BirminghamP2B (60)
Fludeoxyglucose
High Grade B-Cell Lymphoma
University of WashingtonP2B (60)
Fludeoxyglucose
Prostate Neoplasm
National Cancer Institute (NCI)P2B (60)
Fluorouracilum
Ovarian Carcinoma
National Cancer Institute (NCI)P2B (60)
Fluorouracilum
Urothelial Carcinoma
Memorial Sloan Kettering Cancer CenterP2B (60)
Fluorouracilum
Bile Duct Cancer
Lisata Therapeutics, Inc.P2B (60)
Fluorouracilum
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer CenterP2B (60)
Fluorouracilum
Peritoneal Mesothelioma
Hospices Civils de LyonP2B (60)
Flutamide
Polycystic Ovary Syndrome
University of VirginiaP2B (60)
Fruquintinib
Cancer
Fudan UniversityP2B (60)
Fulvestrant
Uterine Cervix Neoplasm
Atavistik Bio, IncP2B (60)
Fulvestrant
Ovarian Carcinoma
Atavistik Bio, IncP2B (60)
Fulvestrant
Female Reproductive Organ Cancer
Atavistik Bio, IncP2B (60)
Fulvestrant
Liposarcoma
PfizerP2B (60)
Fulvestrant
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2B (60)
Fulvestrant
Urinary System Neoplasm
Atavistik Bio, IncP2B (60)
Showing 1801 to 1825 of 13,155 assets
PreviousPage 73 of 527Next